Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors

OMICS A Journal of Integrative Biology

Volumn 15, Issue 6, 2011, Pages 375-381

  Ganci, Federica ^a   Conti, Salvatore ^a   Fontemaggi, Giulia ^a   Manciocco, Valentina ^a   Donzelli, Sara ^a   Covello, Renato ^a   Muti, Paola ^a   Strano, Sabrina ^a   Blandino, Giovanni ^a   Spriano, Giuseppe ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; MESSENGER RNA; PROTEIN P53;

ALLELE; ALLELIC IMBALANCE; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER TISSUE; CELL DIFFERENTIATION; CELL HETEROGENEITY; DNA SEQUENCE; EXON; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMIZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOLECULAR CLONING; MOUTH CAVITY; NONSENSE MUTATION; PHARYNX; POLYMORPHIC ALLELE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79958696379     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0142     Document Type: Article

References (18)

1. Candeias, M.M., Malbert-Colas, L., Powell, D.J., Daskalogianni, C., Maslon, M.M., Naski, N., et al. (2008). P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol 10, 1098-1105.
2. Edström, S., Cvetkovska, E., Westin, T., and Young, C. (2001). Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Laryngoscope 111, 124-130. (Pubitemid 32061963)
3. Goranova, T.E., Ohue, M., and Kato, K. (2009). Putative precursor cancer cells in human colorectal cancer tissue. Int J Clin Exp Pathol 2, 154-162.
4. He, H., Olesnanik, K., Nagy, R., Liyanarachchi, S., Prasad, M.L., Stratakis, C.A., et al. (2005). Allelic variation in gene expression in thyroid tissue. Thyroid 15, 660-667. (Pubitemid 41117517)
5. Huang, J., Hu, N., Goldstein, A.M., Emmert-Buck, M.R., Tang, Z.Z., Roth, M.J., et al. (2000). High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China. Car-cinogenesis 21, 2019-2026.
6. Kiuru, A., Servomaa, K., Grénman, R., Pulkkinen, J., and Rytö-maa, T. (1997). p53 mutations in human head and neck cancer cell lines. Acta Otolaryngol Suppl 529, 237-240. (Pubitemid 27364407)
7. Mühlemann, O., Eberle, A.B., Stalder, L., and Zamudio Orozco, R. (2008). Recognition and elimination of nonsense mRNA. Biochim Biophys Acta 1779, 538-549.
8. Nogueira, C.P., Dolan, R.W., Gooey, J., Byahatti, S., Vaughan, C.W., Fuleihan, N.S., et al. (1998). Inactivation of p53 and amplification of cyclin Dl correlate with clinical outcome in head and neck cancer. Laryngoscope 108, 345-350. (Pubitemid 28136640)
9. Pai, S.I., and Westra, W.H. (2009). Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 4, 49-70.
10. Pilger, D.A., Lopez, P.L., Segal, F., and Leistner-Segal, S. (2007). Analysis of R213R and 13494g→a polymorphisms of the p53 gene in individuals with esophagitis, intestinal metaplasia of the cardia and Barrett's Esophagus compared with a control group. Genomic Med 1, 57-63. (Pubitemid 47319599)
11. Smith, E.M., Rubenstein, L.M., Hoffman, H., Haugen, T.H., and Turek, L.P. (2010). Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 5, 4.
12. Szybka, M., Zawlik, I., Kulczycka, D., Golanska, E., Jesien, E., Kupnicka, D., et al. (2008). Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53. Br J Cancer 98, 1431-1433. (Pubitemid 351543567)
13. Szybka, M., Zakrzewska, M., Rieske, P., Pasz-Walczak, G., Kulczycka-Wojdala, D., Zawlik, I., et al. (2009). cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. BMC Cancer 9, 278.
14. Thomas, G.R., Nadiminti, H., and Regalado, J. (2005). Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86, 347-363. (Pubitemid 41746374)
15. Wang, X., Fan, M., Chen, X., Wang, S., Alsharif, M.J., Wang, L., et al. (2006). Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma. Oral Oncol 42, 740-744. (Pubitemid 44094241)
16. Whibley, C., Pharoah, P.D., and Hollstein, M. (2009). p53 polymorphisms: cancer implications. Nat Rev Cancer 9, 95-107.
17. Williams, C., Norberg, T., Ahmadian, A., Pontén, F., Bergh, J., Inganäs, M., et al. (1998). Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets. Clin Chem 44, 455-462. (Pubitemid 28141338)
18. Yin, J., Harpaz, N., Tong, Y., Huang, Y., Laurin, J., Greenwald, B.D., et al. (1993). p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104, 1633-1639. (Pubitemid 23235452)